epidermolysis bullosa: a group of inherited connective tissue diseases that cause blisters in the skin and mucosal membranes, with an incidence of 20 per million newborns in the United States.It is a result of a defect in anchoring between the epidermis and dermis, resulting in friction and skin fragility. Its severity ranges from mild to lethal.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
54 |
4. Check minimum number of eventsNone |
54 |
5. Include endpointsNone |
54 |
6. Filter based on genotype QC (FinnGen only) |
54 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q8
- Name in latin
- Epidermolysis bullosa
Similar endpoints
↥List of similar endpoints to
Epidermolysis bullosa
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 489 | 266 | 222 |
| Only index persons | 416 | 226 | 190 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 22.22 | 27.80 | 15.49 |
| Only index persons | 22.99 | 28.57 | 16.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 54 | 33 | 21 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 27.18 | 34.31 | 15.99 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 54
- Matched controls
- 540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A98, ,
ICD-O-3
+∞
74.6
53
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
60.1
46
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
54.8
43
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
53.2
42
*
J01DB01, ,
ATC
cefalexin; oral
+∞
53.2
42
*
SAA01, ,
ICD-O-3
+∞
48.4
39
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
42.4
35
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
40.9
34
*
SAA02, ,
ICD-O-3
+∞
40.9
34
*
WX110, ,
ICD-O-3
+∞
39.5
33
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
36.7
31
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
35.3
30
*
J069, ,
ICD-O-3
+∞
34.0
29
*
E0000UV, ,
ATC
+∞
34.0
29
*
GD1AA, ,
ICD-O-3
+∞
34.0
29
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
31.3
27
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
31.3
27
*
-1, ,
ICD-O-3
+∞
30.0
26
*
EB1SA, ,
ICD-O-3
+∞
30.0
26
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
30.0
26
*
K021, ,
ICD-O-3
+∞
28.7
25
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
28.7
25
*
R06AE07, ,
ATC
cetirizine; oral
+∞
27.4
24
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
27.4
24
*
EB1AA, ,
ICD-O-3
+∞
27.4
24
*
J01DA01, ,
ATC
[U] cefalexin
+∞
26.2
23
*
M03BX02, ,
ATC
tizanidine; oral
+∞
26.2
23
*
Q810, ,
ICD-10 Finland
Epidermolysis bullosa simplex
+∞
26.2
23
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
24.9
22
*
ZXE00, ,
ICD-O-3
+∞
24.9
22
*
SCA01, ,
ICD-O-3
+∞
24.9
22
*
R01AD09, ,
ATC
mometasone; nasal
+∞
24.9
22
*
Z012, ,
ICD-O-3
+∞
24.9
22
*
SAA03, ,
ICD-O-3
+∞
24.9
22
*
ZXE10, ,
ICD-O-3
+∞
24.9
22
*
R74, ,
ICD-O-3
+∞
24.9
22
*
KMAK, ,
ICD-O-3
+∞
24.9
22
*
SPAT1249, ,
ICD-O-3
+∞
23.7
21
*
S18, ,
ICD-O-3
+∞
23.7
21
*
SFA10, ,
ICD-O-3
+∞
23.7
21
*
SPAT1312, ,
ICD-O-3
+∞
23.7
21
*
WX290, ,
ICD-O-3
+∞
23.7
21
*
SFA20, ,
ICD-O-3
+∞
23.7
21
*
SPAT1325, ,
ICD-O-3
+∞
22.4
20
*
ZXD10, ,
ICD-O-3
+∞
22.4
20
*
WZC00, ,
ICD-O-3
+∞
22.4
20
*
WYA05, ,
ICD-O-3
+∞
22.4
20
*
WZB00, ,
ICD-O-3
+∞
22.4
20
*
Z3231, ,
ICD-O-3
+∞
22.4
20
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
22.4
20
*
EB1HA, ,
ICD-O-3
+∞
21.2
19
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
21.2
19
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
21.2
19
*
R4110, ,
ICD-O-3
+∞
20.0
18
*
EBA00, ,
ICD-O-3
+∞
20.0
18
*
D07AC01, ,
ATC
betamethasone; topical
+∞
20.0
18
*
R06AX27, ,
ATC
desloratadine; oral
+∞
20.0
18
*
M796, ,
ICD-O-3
+∞
20.0
18
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
20.0
18
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
20.0
18
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
18.8
17
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
18.8
17
*
SPAT1253, ,
ICD-O-3
+∞
18.8
17
*
R05, ,
ICD-O-3
+∞
18.8
17
*
AA1AD, ,
ICD-O-3
+∞
18.8
17
*
SDA02, ,
ICD-O-3
+∞
18.8
17
*
ZXA00, ,
ICD-O-3
+∞
18.8
17
*
D01BA02, ,
ATC
terbinafine; oral
+∞
18.8
17
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
18.8
17
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
18.8
17
*
VALMI, ,
ICD-O-3
+∞
17.6
16
*
D82, ,
ICD-O-3
+∞
17.6
16
*
SPAT1263, ,
ICD-O-3
+∞
17.6
16
*
TQX10, ,
ICD-O-3
+∞
17.6
16
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
17.6
16
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
17.6
16
*
L17, ,
ICD-O-3
+∞
16.5
15
*
OAB43, ,
ICD-O-3
+∞
16.5
15
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
16.5
15
*
WX408, ,
ICD-O-3
+∞
16.5
15
*
WX402, ,
ICD-O-3
+∞
16.5
15
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
16.5
15
*
N06AB10, ,
ATC
escitalopram; oral
+∞
16.5
15
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
16.5
15
*
SPAT1283, ,
ICD-O-3
+∞
16.5
15
*
SPAT1256, ,
ICD-O-3
+∞
15.3
14
*
D07AC13, ,
ATC
mometasone; topical
+∞
15.3
14
*
SDA03, ,
ICD-O-3
+∞
15.3
14
*
Q819, ,
ICD-10 Finland
Epidermolysis bullosa, unspecified
+∞
15.3
14
*
WX404, ,
ICD-O-3
+∞
15.3
14
*
Z315, ,
ICD-10 Finland
Genetic counselling
+∞
15.3
14
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
15.3
14
*
E000001, ,
ATC
+∞
15.3
14
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
15.3
14
*
Z3226, ,
ICD-O-3
+∞
14.2
13
*
M545, ,
ICD-O-3
+∞
14.2
13
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
14.2
13
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
14.2
13
*
UJD10, ,
ICD-O-3
+∞
14.2
13
*
ZXD05, ,
ICD-O-3
+∞
14.2
13
*
R83, ,
ICD-O-3
+∞
14.2
13
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
14.2
13
*
SDA01, ,
ICD-O-3
+∞
14.2
13
*
D19, ,
ICD-O-3
+∞
14.2
13
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
14.2
13
*
SPAT1315, ,
ICD-O-3
+∞
13.0
12
*
N05CF01, ,
ATC
zopiclone; oral
+∞
13.0
12
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
13.0
12
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
13.0
12
*
K0364, ,
ICD-O-3
+∞
13.0
12
*
C03CA01, ,
ATC
furosemide; systemic
+∞
13.0
12
*
UJF32, ,
ICD-O-3
+∞
13.0
12
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
13.0
12
*
J010, ,
ICD-O-3
+∞
13.0
12
*
Q812, ,
ICD-10 Finland
Epidermolysis bullosa dystrophica
+∞
13.0
12
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
13.0
12
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
13.0
12
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
13.0
12
*
Q811, ,
ICD-10 Finland
Epidermolysis bullosa letalis
+∞
13.0
12
*
SFA30, ,
ICD-O-3
+∞
13.0
12
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
13.0
12
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
11.9
11
*
SPAT1153, ,
ICD-O-3
+∞
11.9
11
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
11.9
11
*
Z363, ,
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
+∞
11.9
11
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
11.9
11
*
ZXA05, ,
ICD-O-3
+∞
11.9
11
*
Z718, ,
ICD-O-3
+∞
11.9
11
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
11.9
11
*
R21, ,
ICD-O-3
+∞
11.9
11
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
11.9
11
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
11.9
11
*
L03, ,
ICD-O-3
+∞
11.9
11
*
ZXA10, ,
ICD-O-3
+∞
11.9
11
*
L15, ,
ICD-O-3
+∞
11.9
11
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
11.9
11
*
I10, ,
ICD-O-3
+∞
11.9
11
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
11.9
11
*
N03AX16, ,
ATC
[U] pregabalin
+∞
11.9
11
*
SCA02, ,
ICD-O-3
+∞
11.9
11
*
Z2221, ,
ICD-O-3
+∞
11.9
11
*
Z712, ,
ICD-O-3
+∞
11.9
11
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
10.8
10
*
TPH04, ,
ICD-O-3
+∞
10.8
10
*
Z871, ,
ICD-O-3
+∞
10.8
10
*
D07BA04, ,
ATC
hydrocortisone and antiseptics; topical
+∞
10.8
10
*
N05AH04, ,
ATC
quetiapine; oral
+∞
10.8
10
*
C09CA01, ,
ATC
losartan; oral
+∞
10.8
10
*
A03, ,
ICD-O-3
+∞
10.8
10
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
10.8
10
*
J209, ,
ICD-O-3
+∞
10.8
10
*
M255, ,
ICD-O-3
+∞
10.8
10
*
K045, ,
ICD-O-3
+∞
10.8
10
*
SPAT1301, ,
ICD-O-3
+∞
10.8
10
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
10.8
10
*
E000002, ,
ATC
+∞
10.8
10
*
C08CA01, ,
ATC
amlodipine; oral
+∞
10.8
10
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
10.8
10
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
10.8
10
*
Z760, ,
ICD-O-3
+∞
10.8
10
*
SFC01, ,
ICD-O-3
+∞
10.8
10
*
OAA65, ,
ICD-O-3
+∞
10.8
10
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
10.8
10
*
R104, ,
ICD-O-3
+∞
10.8
10
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
10.8
10
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
10.8
10
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
10.8
10
*
SDA04, ,
ICD-O-3
+∞
10.8
10
*
R03DC03, ,
ATC
montelukast; oral
+∞
10.8
10
*
SAB01, ,
ICD-O-3
+∞
10.8
10
*
EBA05, ,
ICD-O-3
+∞
10.8
10
*
LC2BE, ,
ICD-O-3
+∞
10.8
10
*
AA1BG, ,
ICD-O-3
+∞
10.8
10
*
D07BB04, ,
ATC
hydrocortisone butyrate and antiseptics; topical
+∞
10.8
10
*
SPAT1223, ,
ICD-O-3
+∞
10.8
10
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
10.8
10
*
C10AA01, ,
ATC
simvastatin; oral
+∞
9.7
9
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
9.7
9
*
NG1AA, ,
ICD-O-3
+∞
9.7
9
*
S21, ,
ICD-O-3
+∞
9.7
9
*
O800, ,
ICD-10 Finland
Spontaneous vertex delivery
+∞
9.7
9
*
M02AA07, ,
ATC
piroxicam; topical
+∞
9.7
9
*
N01, ,
ICD-O-3
+∞
9.7
9
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
9.7
9
*
Q818, ,
ICD-10 Finland
Other epidermolysis bullosa
+∞
9.7
9
*
Z508, ,
ICD-10 Finland
Care involving use of other rehabilitation procedures
+∞
9.7
9
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
9.7
9
*
D07AB08, ,
ATC
desonide; topical
+∞
9.7
9
*
L309, ,
ICD-O-3
+∞
9.7
9
*
R06AX13, ,
ATC
loratadine; oral
+∞
9.7
9
*
C09AA05, ,
ATC
ramipril; oral
+∞
9.7
9
*
MA2AE, ,
ICD-O-3
+∞
9.7
9
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
9.7
9
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
9.7
9
*
QAE10, ,
ICD-O-3
+∞
9.7
9
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
9.7
9
*
SPAT1310, ,
ICD-O-3
+∞
9.7
9
*
SPAT1316, ,
ICD-O-3
+∞
8.5
8
*
65000, ,
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
+∞
8.5
8
*
D01AE15, ,
ATC
terbinafine; topical
+∞
8.5
8
*
S29, ,
ICD-O-3
+∞
8.5
8
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
8.5
8
*
W78, ,
ICD-O-3
+∞
8.5
8
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
8.5
8
*
D02AX, ,
ATC
Other emollients and protectives
+∞
8.5
8
*
R103, ,
ICD-O-3
+∞
8.5
8
*
F329, ,
ICD-10 Finland
Depressive episode, unspecified
+∞
8.5
8
*
SPAT1308, ,
ICD-O-3
+∞
8.5
8
*
WZA90, ,
ICD-O-3
+∞
8.5
8
*
C09CA06, ,
ATC
candesartan; oral
+∞
8.5
8
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
8.5
8
*
WX700, ,
ICD-O-3
+∞
8.5
8
*
R53, ,
ICD-O-3
+∞
8.5
8
*
SPAT1317, ,
ICD-O-3
+∞
8.5
8
*
SDE03, ,
ICD-O-3
+∞
8.5
8
*
K0510, ,
ICD-O-3
+∞
8.5
8
*
Z048, ,
ICD-10 Finland
Examination and observation for other specified reasons
+∞
8.5
8
*
D01, ,
ICD-O-3
+∞
8.5
8
*
M01AH01, ,
ATC
celecoxib; oral
+∞
8.5
8
*
D11, ,
ICD-O-3
+∞
8.5
8
*
L01, ,
ICD-O-3
+∞
8.5
8
*
JN1AE, ,
ICD-O-3
+∞
8.5
8
*
D06AX01, ,
ATC
fusidic acid; topical
+∞
8.5
8
*
EBA10, ,
ICD-O-3
+∞
8.5
8
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
8.5
8
*
S060, ,
ICD-10 Finland
Concussion
+∞
8.5
8
*
M751, ,
ICD-O-3
+∞
8.5
8
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
8.5
8
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
8.5
8
*
WW200, ,
ICD-O-3
+∞
8.5
8
*
XQ800, ,
ICD-O-3
+∞
8.5
8
*
L200, ,
ICD-10 Finland
Besnier prurigo
+∞
8.5
8
*
ZXE20, ,
ICD-O-3
+∞
8.5
8
*
P01, ,
ICD-O-3
+∞
8.5
8
*
SPAT1363, ,
ICD-O-3
+∞
8.5
8
*
XF400, ,
ICD-O-3
+∞
8.5
8
*
ZXD20, ,
ICD-O-3
+∞
7.5
7
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
7.5
7
*
FM1BE, ,
ICD-O-3
+∞
7.5
7
*
C09AA02, ,
ATC
enalapril; systemic
+∞
7.5
7
*
M01AX17, ,
ATC
nimesulide; oral
+∞
7.5
7
*
Z000, ,
ICD-O-3
+∞
7.5
7
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
7.5
7
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
7.5
7
*
SPAT1197, ,
ICD-O-3
+∞
7.5
7
*
GD1QA, ,
ICD-O-3
+∞
7.5
7
*
L02, ,
ICD-O-3
+∞
7.5
7
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
7.5
7
*
R060, ,
ICD-O-3
+∞
7.5
7
*
FM1DE, ,
ICD-O-3
+∞
7.5
7
*
NH1AA, ,
ICD-O-3
+∞
7.5
7
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
7.5
7
*
SFA40, ,
ICD-O-3
+∞
7.5
7
*
DM1QA, ,
ICD-O-3
+∞
7.5
7
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
7.5
7
*
N02AE01, ,
ATC
buprenorphine; parenteral, sublingual, transdermal
+∞
7.5
7
*
L28, ,
ICD-O-3
+∞
7.5
7
*
SPAT1386, ,
ICD-O-3
+∞
7.5
7
*
C03DA01, ,
ATC
spironolactone; oral
+∞
7.5
7
*
QBE10, ,
ICD-O-3
+∞
7.5
7
*
B01AA03, ,
ATC
warfarin; systemic
+∞
7.5
7
*
J01MA06, ,
ATC
norfloxacin; oral
+∞
7.5
7
*
D07CC01, ,
ATC
betamethasone and antibiotics; topical
+∞
7.5
7
*
W19, ,
ICD-10 Finland
Unspecified fall
+∞
7.5
7
*
JN3AE, ,
ICD-O-3
+∞
7.5
7
*
L16, ,
ICD-O-3
+∞
7.5
7
*
N06AX21, ,
ATC
duloxetine; oral
+∞
7.5
7
*
OAB48, ,
ICD-O-3
+∞
7.5
7
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
7.5
7
*
P06, ,
ICD-O-3
+∞
7.5
7
*
SDE02, ,
ICD-O-3
+∞
7.5
7
*
FM1AE, ,
ICD-O-3
+∞
7.5
7
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
7.5
7
*
JN3AD, ,
ICD-O-3
+∞
7.5
7
*
K020, ,
ICD-O-3
+∞
7.5
7
*
M751, ,
ICD-10 Finland
Rotator cuff syndrome
+∞
7.5
7
*
W00, ,
ICD-10 Finland
Fall on same level involving ice and snow
+∞
7.5
7
*
XF404, ,
ICD-O-3
+∞
7.5
7
*
WX002, ,
ICD-O-3
+∞
7.5
7
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
7.5
7
*
ZYC01, ,
ICD-O-3
+∞
7.5
7
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
7.5
7
*
L08, ,
ICD-O-3
+∞
7.5
7
*
R06AX22, ,
ATC
ebastine; oral
+∞
7.5
7
*
G473, ,
ICD-O-3
+∞
6.4
6
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
6.4
6
*
L13, ,
ICD-O-3
+∞
6.4
6
*
H13, ,
ICD-O-3
+∞
6.4
6
*
W11, ,
ICD-O-3
+∞
6.4
6
*
N05CF02, ,
ATC
zolpidem; oral
+∞
6.4
6
*
L12, ,
ICD-O-3
+∞
6.4
6
*
Z001, ,
ICD-O-3
+∞
6.4
6
*
ZXE11, ,
ICD-O-3
+∞
6.4
6
*
N05BA04, ,
ATC
oxazepam; oral
+∞
6.4
6
*
H660, ,
ICD-10 Finland
Acute suppurative otitis media
+∞
6.4
6
*
Z017, ,
ICD-O-3
+∞
6.4
6
*
B01AF02, ,
ATC
apixaban; oral
+∞
6.4
6
*
WYA30, ,
ICD-O-3
+∞
6.4
6
*
H669, ,
ICD-10 Finland
Otitis media, unspecified
+∞
6.4
6
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
6.4
6
*
SPAT1379, ,
ICD-O-3
+∞
6.4
6
*
R21, ,
ICD-10 Finland
Rash and other nonspecific skin eruption
+∞
6.4
6
*
ZXD30, ,
ICD-O-3
+∞
6.4
6
*
M01AG02, ,
ATC
tolfenamic acid; oral, rectal
+∞
6.4
6
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
6.4
6
*
K0365, ,
ICD-O-3
+∞
6.4
6
*
SHA02, ,
ICD-O-3
+∞
6.4
6
*
FM1EE, ,
ICD-O-3
+∞
6.4
6
*
TQW80, ,
ICD-O-3
+∞
6.4
6
*
TQW99, ,
ICD-O-3
+∞
6.4
6
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
6.4
6
*
N02CC01, ,
ATC
sumatriptan; nasal, systemic, rectal
+∞
6.4
6
*
TPH07, ,
ICD-O-3
+∞
6.4
6
*
R2130, ,
ICD-O-3
+∞
6.4
6
*
SPAT1262, ,
ICD-O-3
+∞
6.4
6
*
XCW99, ,
ICD-O-3
+∞
6.4
6
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
6.4
6
*
Z2445, ,
ICD-O-3
+∞
6.4
6
*
Z090, ,
ICD-10 Finland
Follow-up examination after surgery for other conditions
+∞
6.4
6
*
Z2446, ,
ICD-O-3
+∞
6.4
6
*
SAB02, ,
ICD-O-3
+∞
6.4
6
*
F510, ,
ICD-O-3
+∞
6.4
6
*
R5110, ,
ICD-O-3
+∞
6.4
6
*
E000007, ,
ATC
+∞
6.4
6
*
D06BX01, ,
ATC
metronidazole; topical
+∞
6.4
6
*
A28, ,
ICD-O-3
+∞
6.4
6
*
SPAT1222, ,
ICD-O-3
+∞
6.4
6
*
R529, ,
ICD-O-3
+∞
6.4
6
*
M544, ,
ICD-10 Finland
Lumbago with sciatica
+∞
6.4
6
*
A04, ,
ICD-O-3
+∞
6.4
6
*
Z392, ,
ICD-O-3
+∞
6.4
6
*
J451, ,
ICD-10 Finland
Nonallergic asthma
+∞
6.4
6
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
6.4
6
*
SPAT1307, ,
ICD-O-3
+∞
6.4
6
*
O244, ,
ICD-10 Finland
Diabetes mellitus arising in pregnancy
+∞
6.4
6
*
Z3229, ,
ICD-O-3
+∞
6.4
6
*
SPAT1324, ,
ICD-O-3
+∞
6.4
6
*
L11, ,
ICD-O-3
+∞
6.4
6
*
R03BA01, ,
ATC
beclometasone; inhalant
+∞
6.4
6
*
QDE10, ,
ICD-O-3
+∞
6.4
6
*
R42, ,
ICD-10 Finland
Dizziness and giddiness
+∞
6.4
6
*
D07AD01, ,
ATC
clobetasol; topical
+∞
6.4
6
*
SPAT1306, ,
ICD-O-3
+∞
6.4
6
*
NH3AA, ,
ICD-O-3
+∞
6.4
6
*
U072, ,
ICD-O-3
+∞
6.4
6
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
6.4
6
*
XA800, ,
ICD-O-3
+∞
6.4
6
*
WX320, ,
ICD-O-3
+∞
6.4
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
12
22
6.69
4.95
19.9
7.0
116.92
121.41
g/l
0.34
12
22
13
27
5.99
4.89
18.5
6.9
10.92
15.36
kpa
2.03
13
27
13
27
5.99
4.89
18.5
6.9
5.05
5.25
kpa
0.28
13
27
9
13
8.05
4.36
21.7
9.7
22.80
24.58
mmol/l
—
9
13
29
147
3.10
4.03
19.8
10.7
1.06
1.17
inr
—
7
47
9
17
6.12
3.69
8.0
5.9
0.61
0.78
%
—
9
17
9
17
6.12
3.69
8.0
5.9
1.19
1.24
%
—
9
17
6
9
7.33
2.95
2.5
1.4
—
—
—
0
0
31
203
2.24
2.15
3.9
3.2
0.00
0.00
estimate
—
8
39
7
20
3.86
2.13
1.6
2.3
—
—
—
0
0
31
204
2.22
2.12
3.8
3.2
0.00
0.00
estimate
—
8
35
13
58
2.63
2.11
1.7
2.0
—
—
—
0
0
23
137
2.18
1.98
3.2
3.8
—
—
—
0
0
19
105
2.25
1.95
3.9
3.3
0.00
0.00
estimate
—
8
39
25
156
2.12
1.90
12.0
7.3
35.26
37.17
g/l
0.97
25
149
30
201
2.11
1.89
5.3
4.6
0.00
0.00
estimate
—
8
38
10
40
2.83
1.78
9.7
9.5
103.90
104.03
mmol/l
—
10
40
10
41
2.76
1.76
1.6
1.9
—
—
—
0
0
10
42
2.69
1.73
1.9
1.8
—
—
—
0
0
6
19
3.42
1.71
3.5
9.8
92.00
100.21
%
—
6
19
26
174
1.95
1.57
4.2
2.7
—
—
—
0
0
7
28
2.72
1.51
5.0
3.7
—
—
—
0
0
5
16
3.33
1.47
3.8
11.4
3.26
2.84
g/l
—
5
16
19
118
1.94
1.39
2.8
2.9
21.14
20.14
ng/l
0.04
14
60
13
70
2.13
1.38
3.1
2.3
60.83
74.18
ng/l
—
6
39
5
105
0.42
1.17
1.4
2.3
—
—
—
0
0
23
161
1.75
1.13
21.8
10.3
1.18
1.22
mmol/l
2.28
23
150
11
60
2.05
1.12
1.6
1.6
445.00
521.82
pmol/l
0.43
11
55
7
33
2.28
1.10
1.6
1.4
—
—
—
0
0
49
438
2.28
1.03
27.6
13.0
3.83
3.92
mmol/l
1.17
49
429
49
437
2.31
1.03
27.3
12.7
139.02
139.74
mmol/l
1.40
49
429
9
51
1.92
1.00
7.6
13.1
5.50
5.73
kpa
—
9
51
14
89
1.77
0.92
5.0
2.5
—
—
—
0
0
8
43
2.01
0.92
1.8
4.8
191.38
256.05
u/l
—
8
43
5
99
0.46
0.88
1.4
2.1
—
—
—
0
0
22
164
1.58
0.80
3.7
2.8
—
—
—
0
0
9
56
1.73
0.77
2.3
2.9
2.42
2.42
mmol/l
—
9
46
49
449
1.98
0.75
22.3
12.8
28.91
20.52
mg/l
0.82
40
310
7
40
1.86
0.75
14.7
15.5
24.67
24.95
mmol/l
—
7
40
5
30
1.73
0.63
1.4
2.0
23.64
23.73
iu/l
—
5
23
0
19
0.00
0.61
0.0
1.1
—
—
—
0
0
0
19
0.00
0.61
0.0
1.5
—
2.57
—
0
14
43
387
1.55
0.56
3.7
3.5
1.44
1.49
mmol/l
0.37
43
369
6
39
1.60
0.55
7.7
13.7
24.00
23.59
mmol/l
—
6
39
43
390
1.50
0.50
3.9
3.6
4.70
4.68
mmol/l
0.04
43
374
7
47
1.56
0.50
2.3
1.5
1381.00
1138.66
nmol/l
—
7
34
43
391
1.49
0.49
4.3
3.8
2.94
2.83
mmol/l
0.28
43
374
17
135
1.38
0.42
3.3
3.8
2.32
2.35
mmol/l
0.41
17
124
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
5
35
1.47
0.40
11.2
5.4
—
—
—
0
0
5
76
0.62
0.39
1.4
2.2
1.96
1.37
%
—
5
71
20
168
1.30
0.34
3.2
3.3
69.93
72.80
nmol/l
0.15
20
155
42
391
1.33
0.31
3.5
3.5
—
—
—
0
0
10
77
1.37
0.28
1.1
1.6
17.79
20.78
nmol/l
—
10
66
33
305
1.21
0.22
4.6
4.0
60.27
39.80
u/l
0.60
33
294
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
51.78
—
0
11
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
5.72
—
0
5
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
7
62
1.15
0.18
1.4
2.2
379.71
346.00
nmol/l
—
7
56
10
83
1.25
0.17
2.2
4.4
323.80
329.47
umol/l
—
10
77
16
141
1.19
0.16
2.0
1.5
—
—
—
0
0
5
45
1.12
0.10
1.8
1.7
—
—
—
0
0
39
383
1.07
0.02
12.4
9.7
86.16
93.82
ml/min/173m2
0.84
30
287
35
352
0.98
0.00
4.1
4.1
35.30
37.97
mmol/mol
1.98
35
335
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
7
74
0.94
-0.00
1.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
102.50
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
92.40
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
-0.00
0.0
1.0
—
139.60
—
0
5
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
394.20
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
2.40
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_EPIDERMOL_BULLOSA and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_EPIDERMOL_BULLOSA.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_EPIDERMOL_BULLOSA – Epidermolysis bullosa
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data